These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13274619)

  • 1. [Suavitil, a new compound with specific effect on the central nervous system].
    JACOBSEN E
    Ugeskr Laeger; 1955 Sep; 117(35):1147-51. PubMed ID: 13274619
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical trial of benactyzine hydrochloride (suavitil) as a physical relaxant.
    COADY A; JEWESBURY EC
    Br Med J; 1956 Mar; 1(4965):485-7. PubMed ID: 13293359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Suavitil; a new spasmolytic with a presumptive effect on obsessive-compulsive and related disorders].
    OSTENFELD I
    Nord Med; 1955 Oct; 54(40):1523-5. PubMed ID: 13280113
    [No Abstract]   [Full Text] [Related]  

  • 4. On the effect of suavitil (benzilic acid diethylaminoethylester hydrochloride) on the higher mental functions of normal subjects.
    MUNRO HK
    Acta Psychiatr Neurol Scand; 1955; 30(5):721-8. PubMed ID: 13301923
    [No Abstract]   [Full Text] [Related]  

  • 5. The general pharmacology of benzilic acid diethylaminoethylester hydrochloride (benactyzine NFN, suavitil, parasan).
    LARSEN V
    Acta Pharmacol Toxicol (Copenh); 1955; 11(4):405-20. PubMed ID: 13301792
    [No Abstract]   [Full Text] [Related]  

  • 6. Suavitil in the treatment of psychoneuroses.
    JENSEN OO
    Dan Med Bull; 1955 Sep; 2(5):140-3. PubMed ID: 13261604
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ritalin, a new synthetic compound with specific analeptic components].
    MEIER R; GROSS F; TRIPOD J
    Klin Wochenschr; 1954 May; 32(19-20):445-50. PubMed ID: 13164273
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropharmacological study of the central effects of benactyzine and hydroxyzine (cerebral electrical activity, alarm and flight reaction on hypothalamic stimulation, central antagonisms).
    SILVESTRINI B
    Arch Int Pharmacodyn Ther; 1958 Aug; 116(1-2):71-85. PubMed ID: 13584039
    [No Abstract]   [Full Text] [Related]  

  • 9. An analysis of the activating system including its use for screening antiParkinson drugs.
    HIMWICH HE; RINALDI F
    Yale J Biol Med; 1955 Dec-1956 Feb; 28(3-4):308-19. PubMed ID: 13291855
    [No Abstract]   [Full Text] [Related]  

  • 10. Central and peripheral nervous effects of atropine sulfate and mepiperphenidol bromide (darstine) on human subjects.
    WHITE RP; RINALDI F; HIMWICH HE
    J Appl Physiol; 1956 May; 8(6):635-42. PubMed ID: 13331850
    [No Abstract]   [Full Text] [Related]  

  • 11. On certain correlations between cholinergic blocking drugs, convulsive excitability of the central nervous system and the anticonvulsive acitivity of the anticonvulsants.
    Roussinov KS
    Izv Inst Fiziol (Sofiia); 1968; 11():169-77. PubMed ID: 5684380
    [No Abstract]   [Full Text] [Related]  

  • 12. Rating scale for autonomic, motor and central effects in dogs. Effects of anticholinergic and cholinergic drugs.
    Kabes J
    Act Nerv Super (Praha); 1972 Aug; 14(3):164-5. PubMed ID: 5052804
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxic, spasmolytic and local anesthetic effect of basic phenylacetyl derivatives].
    HOHENSEE F
    Arzneimittelforschung; 1954 Oct; 4(10):598-601. PubMed ID: 13219021
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis of spasmolytic drugs alpha-piperidino-alpha-phenyl acetic acid esters and alpha-amino-alpha-phenyl-acetic acid esters].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1952; 22(7):332-8. PubMed ID: 12986804
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis and pharmacological activity of ethyl N-acetic and N-malonic esters of heterocyclic derivatives].
    Cheav SL; Goma JR; Pieri F; Kirkiacharian S
    Ann Pharm Fr; 1993; 51(1):37-46. PubMed ID: 8215120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of action on the central nervous system of cholinolytic substances blocking M- and N-choline-reactive systems].
    KRYLOV SS
    Fiziol Zh SSSR Im I M Sechenova; 1955; 41(4):575-81. PubMed ID: 13262185
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the central and peripheral pharmacological properties of 1-(2 dimethylaminoethyl)-1-phenylidene].
    Buchel L; Levy J
    Therapie; 1968; 23(5):1135-46. PubMed ID: 4387506
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on spasmolytics. III. The effect of structural changes in nitrogen-free spasmolytic esters: (a) alpha-chlorophenylacetic acid ester: (b) phenylglyoxylic acid ester].
    FUNCKE AB; REKKER RF; ERNSTING MJ; NAUTA WT
    Arzneimittelforschung; 1956 Feb; 6(2):60-1. PubMed ID: 13315065
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of substituted derivatives of phenyldiallylacetamide on the central nervous system.
    Zak A; Prastowski W
    Arch Immunol Ther Exp (Warsz); 1966; 14(5):657-61. PubMed ID: 5923830
    [No Abstract]   [Full Text] [Related]  

  • 20. Antispasmodics. II. alpha-Amino-alpha-pyridylacetonitriles and derivatives.
    JANSSEN P; ZIVKOVIC D; DEMOEN P
    J Am Pharm Assoc Am Pharm Assoc; 1955 Aug; 44(8):465-7. PubMed ID: 13242439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.